| TGF-β superfamily signaling in embryonic development and homeostasis MY Wu, CS Hill Developmental cell 16 (3), 329-343, 2009 | 941 | 2009 |
| Neutralising antibody activity against SARS-CoV-2 VOCs B. 1.617. 2 and B. 1.351 by BNT162b2 vaccination EC Wall, M Wu, R Harvey, G Kelly, S Warchal, C Sawyer, R Daniels, ... The Lancet 397 (10292), 2331-2333, 2021 | 600 | 2021 |
| Pandemic peak SARS-CoV-2 infection and seroconversion rates in London frontline health-care workers CF Houlihan, N Vora, T Byrne, D Lewer, G Kelly, J Heaney, S Gandhi, ... The Lancet 396 (10246), e6-e7, 2020 | 248 | 2020 |
| Adaptive immunity and neutralizing antibodies against SARS-CoV-2 variants of concern following vaccination in patients with cancer: the CAPTURE study A Fendler, STC Shepherd, L Au, KA Wilkinson, M Wu, F Byrne, M Cerrone, ... Nature cancer 2 (12), 1305-1320, 2021 | 161 | 2021 |
| AZD1222-induced neutralising antibody activity against SARS-CoV-2 Delta VOC EC Wall, M Wu, R Harvey, G Kelly, S Warchal, C Sawyer, R Daniels, ... The Lancet 398 (10296), 207-209, 2021 | 132 | 2021 |
| Endoplasmic reticulum dynamics, inheritance, and cytoskeletal interactions in budding yeast KL Fehrenbacher, D Davis, M Wu, I Boldogh, LA Pon Molecular biology of the cell 13 (3), 854-865, 2002 | 114 | 2002 |
| Three-dose vaccination elicits neutralising antibodies against omicron M Wu, EC Wall, EJ Carr, R Harvey, H Townsley, HV Mears, L Adams, ... The Lancet 399 (10326), 715-717, 2022 | 99 | 2022 |
| Neutralising antibodies after COVID-19 vaccination in UK haemodialysis patients EJ Carr, M Wu, R Harvey, EC Wall, G Kelly, S Hussain, M Howell, ... The Lancet 398 (10305), 1038-1041, 2021 | 92 | 2021 |
| Induction of APOBEC3 exacerbates DNA replication stress and chromosomal instability in early breast and lung cancer evolution S Venkatesan, M Angelova, C Puttick, H Zhai, DR Caswell, WT Lu, ... Cancer discovery 11 (10), 2456-2473, 2021 | 90 | 2021 |
| Omicron neutralising antibodies after third COVID-19 vaccine dose in patients with cancer A Fendler, STC Shepherd, L Au, M Wu, R Harvey, AM Schmitt, Z Tippu, ... The Lancet 399 (10328), 905-907, 2022 | 76 | 2022 |
| SARS-CoV-2 S2–targeted vaccination elicits broadly neutralizing antibodies KW Ng, N Faulkner, K Finsterbusch, M Wu, R Harvey, S Hussain, M Greco, ... Science translational medicine 14 (655), eabn3715, 2022 | 73 | 2022 |
| Microbial communities form rich extracellular metabolomes that foster metabolic interactions and promote drug tolerance JSL Yu, C Correia-Melo, F Zorrilla, L Herrera-Dominguez, MY Wu, J Hartl, ... Nature microbiology 7 (4), 542-555, 2022 | 67 | 2022 |
| Immune responses following third COVID-19 vaccination are reduced in patients with hematological malignancies compared to patients with solid cancer A Fendler, STC Shepherd, L Au, KA Wilkinson, M Wu, AM Schmitt, Z Tippu, ... Cancer Cell 40 (2), 114-116, 2022 | 67 | 2022 |
| Identifying SARS-CoV-2 antiviral compounds by screening for small molecule inhibitors of nsp14/nsp10 exoribonuclease B Canal, AW McClure, JF Curran, M Wu, R Ulferts, F Weissmann, J Zeng, ... Biochemical Journal 478 (13), 2445-2464, 2021 | 60 | 2021 |
| Functional antibody and T cell immunity following SARS-CoV-2 infection, including by variants of concern, in patients with cancer: the CAPTURE study A Fendler, L Au, STC Shepherd, F Byrne, M Cerrone, LA Boos, ... Nature Cancer 2 (12), 1321-1337, 2021 | 57 | 2021 |
| Identifying SARS-CoV-2 antiviral compounds by screening for small molecule inhibitors of nsp13 helicase J Zeng, F Weissmann, AP Bertolin, V Posse, B Canal, R Ulferts, M Wu, ... Biochemical Journal 478 (13), 2405-2423, 2021 | 52 | 2021 |
| Reduced antibody cross-reactivity following infection with B. 1.1. 7 than with parental SARS-CoV-2 strains N Faulkner, KW Ng, MY Wu, R Harvey, M Margaritis, S Paraskevopoulou, ... Elife 10, e69317, 2021 | 51 | 2021 |
| SNW1 is a critical regulator of spatial BMP activity, neural plate border formation, and neural crest specification in vertebrate embryos MY Wu, MC Ramel, M Howell, CS Hill PLoS Biology 9 (2), e1000593, 2011 | 50 | 2011 |
| Targeting the conserved stem loop 2 motif in the SARS-CoV-2 genome V Lulla, MP Wandel, KJ Bandyra, R Ulferts, M Wu, T Dendooven, X Yang, ... Journal of virology 95 (14), 10.1128/jvi. 00663-21, 2021 | 47 | 2021 |
| WHO's Therapeutics and COVID-19 Living Guideline on mAbs needs to be reassessed MY Wu, EJ Carr, R Harvey, HV Mears, S Kjaer, H Townsley, A Hobbs, ... The Lancet 400 (10369), 2193-2196, 2022 | 45 | 2022 |
